Abstract 1: Antegrade Flow Across an Intracranial Occlusion Can be Reliably Assessed on Ct Perfusion Source Images and it Predicts Recanalization With Intravenous Tpa
Background: We aimed to see if antegrade flow observed on CT Perfusion Source Images (CTPSi) across an intracranial occlusion correlated with first run of DSA and predicted recanalization on DSA or repeat CTA.
Methods: Patients with acute ischemic stroke and large vessel intracranial occlusion on CTA who had a CT Perfusion study followed by DSA or repeat CTA 4-6 hours later were included. CT Perfusion parameters were 8 cm coverage in static mode, acquisitions at 5 mm thickness, 5 seconds delay after contrast & 24 passes over 66 seconds. Antegrade flow was defined as the presence of ‘clot enhancement’ sign on the 1st pass of CTPSi and increasing density of contrast permeating the clot and filling the vessel distal to the occlusion on the 2nd and 3rd passes of CTPSi (Fig 1 & 2). This was correlated with the first run of DSA and recanalization was assessed on DSA (Group 1) or repeat CTA (Group 2).
Results: Total 56 patients were included. In group 1(n=35), antegrade flow on CTPSI was present in 14/35 patients (40%). All these patients had antegrade flow on DSA and 12 of them showed early recanalization (TICI 2a, 2b or 3). IV t-PA was received by 29/35 patients. The sensitivity and specificity of CTPSi to predict antegrade flow when compared to DSA was 86.7% (95% CI, 59.5 - 98.3) and 95% (95% CI, 75.1 - 99.9) respectively. In Group 2 (n=21), antegrade flow was seen on CTPSI in 13 patients (62%) and all of them recanalized with IV t-PA. Six out of 8 patients without antegrade flow on CTPSi did not recanalize.
Conclusion: Antegrade flow across an occlusion can be reliably assessed on initial passes of CTPSi and it predicts recanalization with IV t-PA.
Author Disclosures: S. Mishra: None. M. Eesa: None. M. Almekhlafi: None. E. Qazi: None. M. Goyal: Speakers' Bureau; Modest; Covidien EV3. Research Grant; Significant; Institutional grant for ESCAPE trial from Covidien EV3. Consultant/Advisory Board; Significant; Covidien EV3 for help with design and execution of SWIFT PRIME. B. Menon: None. A. Demchuk: None.
- © 2014 by American Heart Association, Inc.